Abstract
Background
How the early phase allergic reaction affects the late phase reaction remains unclear. We examined this issue with an experimental model of allergic conjunctivitis that permits the two reactions to be disconnected from each other.
Methods
Experimental immune-mediated blepharoconjunctivitis (EC) was initiated in Brown Norway rats by transferring ovalbumin (OVA)-specific T cells and then challenging with OVA-containing eye drops. To induce early phase reaction, a mast-cell activator, C48/80, was challenged together with or without OVA. Rats were evaluated clinically and eyes were harvested for histologic examination and for evaluation of chemokine expression by reverse-transcriptase PCR.
Results
The rats challenged with OVA alone developed the T-cell-mediated late phase reaction histologically, but not clinically, in the absence of early phase reaction. While rats challenged with C48/80 with or without OVA exhibited clinical signs of the early phase reaction, the clinical late phase reaction was observed only in the OVA+C48/80 group. Eosinophilic infiltration into the conjunctiva during the late phase reaction of the OVA+C48/80 group markedly exceeded that of rats challenged with either OVA or C48/80 alone. RANTES (regulated on activation, normal T-cell expressed and secreted), an eosinophil attractant, was expressed both in the OVA+C48/80 and OVA groups, while eotaxin was expressed at equivalent levels in all three groups.
Conclusion
The mast-cell-mediated early phase reaction potentiates the T-cell-mediated late phase reaction, and RANTES is involved in eosinophilic infiltration induced by antigen-specific T cells. Other molecules induced by allergen-specific T cells activated in an as yet unknown manner by the mast cells may be responsible for the infiltration of eosinophils.
Similar content being viewed by others
Abbreviations
- Ab:
-
antibody
- AC:
-
allergic conjunctivitis
- BN:
-
Brown Norway
- C48/80:
-
compound 48/80
- CFA:
-
complete Freund's adjuvant
- cpm:
-
counts per minute
- dNTPs:
-
deoxyribonucleoside triphosphates
- EC:
-
experimental immune-mediated blepharoconjunctivitis
- ELISA:
-
enzyme-linked immunosorbent assay
- FCS:
-
fetal calf serum
- Ig:
-
immunoglobulin
- IL:
-
interleukin
- JRU:
-
Japan reference units
- 2-ME:
-
2-mercaptoethanol
- OVA:
-
ovalbumin
- RANTES:
-
regulated on activation, normal T-cell expressed and secreted
- RT-PCR:
-
reverse-transcriptase polymerase chain reaction
References
Bischoff SC, Sellge G, Manns MP, et al (2001) Interleukin-4 induces a switch of human intestinal mast cells from proinflammatory cells to Th2-type cells. Int Arch Allergy Immunol 124:151–154
Bonini S, Ghinelli E (2000) The early and late phase of the ocular allergic reaction. Acta Ophthalmol Scand 230:41
Calhoun WJ, Sedgwick J, Busse WW (1991) The role of eosinophils in the pathophysiology of asthma. Ann N Y Acad Sci 629:62–72
Fukagawa K, Nakajima T, Tsubota K, et al (1999) Presence of eotaxin in tears of patients with atopic keratoconjunctivitis with severe corneal damage. J Allergy Clin Immunol 103:1220–1221
Fukushima A, Nishino K, Yoshida O, et al (1998) Characterization of the immunopathogenic responses to ovalbumin peptide 323–339 in experimental immune-mediated blepharoconjunctivitis in Lewis rats. Curr Eye Res 17:763–769
Fukushima A, Fukata K, Ozaki A, et al (2003) Exertion of the suppressive effects of IFN-γ on experimental immune-mediated blepharoconjunctivitis in Brown Norway rats during the induction phase but not the effector phase. Br J Ophthalmol (in press)
Gronneberg R, Strandberg K, Stalenheim G, et al (1981) Effect in man of anti-allergic drugs on the immediate and late phase cutaneous allergic reactions induced by anti-IgE. Allergy 36:201–208
Hamelmann E, Gelfand EW (2001) IL-5-induced airway eosinophilia--the key to asthma? Immunol Rev 179:182–191
Hingorani M, Calder V, Jolly G, et al (1998) Eosinophil surface antigen expression and cytokine production vary in different ocular allergic diseases. J Allergy Clin Immunol 102:821–830
Iwamoto H, Nishino K, Magone TM, et al (2000) Experimental immune-mediated blepharoconjunctivitis in rats induced by immunization with ragweed pollen. Graefes Arch Clin Exp Ophthalmol 238:346–351
John M, Hirst SJ, Jose PJ, et al (1997) Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines: regulation by T helper 2 cytokines and corticosteroids. J Immunol 158:1841–1847
Joss JD, Craig TJ (1999) Seasonal allergic conjunctivitis: overview and treatment update. J Am Osteopath Assoc 99:13–18
Kaplan AP, Kuna P (1998) Chemokines and the late-phase reaction. Allergy 53:27–32
Kobayashi T, Miura T, Haba T, et al (2000) An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model. J Immunol 164:3855–3861
Lebman DA, Coffman RL (1988) Interleukin 4 causes isotype switching to IgE in T cell-stimulated clonal B cell cultures. J Exp Med 168:853–862
Lewis SJ, Quinn MJ, Fennessy MR, Jarrott B (1986) The effects of intracerebroventricular administration of compound 48/80 on behaviour and regional brain amine concentrations in the rat. Neurosci Lett 65:84–88
Li Q, Luyo D, Hikita N, et al (1996) Compound 48/80-induced conjunctivitis in the mouse: kinetics, susceptibility, and mechanism. Int Arch Allergy Immunol 109:277–285
Maggi E, Biswas P, Del Prete G, et al (1991) Accumulation of Th-2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J Immunol 146:1169–1174
Magone MT, Chan CC, Rizzo LV, et al (1998) A novel murine model of allergic conjunctivitis. Clin Immunol Immunopathol 87:75–84
Martin JG, Xu LJ, Toh MY, et al (1993) Leukotrienes in bile during the early and the late airway responses after allergen challenge of sensitized rats. Am Rev Respir Dis 147:104–110
Misawa M, Takenouchi K, Shirakawa Y, et al (1987) Effects of mast cell stabilizers on a new bronchial asthma model using compound 48/80 in dogs. Jpn J Pharmacol 44:197–205
Miyamasu M, Misaki Y, Yamaguchi M, et al (2000) Regulation of human eotaxin generation by Th1-/Th2-derived cytokines. Int Arch Allergy Immunol 122:54–58
Nagai H, Abe T, Yamaguchi I, et al (2000) Role of mast cells in the onset of IgE-mediated late-phase cutaneous response in mice. J Allergy Clin Immunol 106:91–98
Noviski N, Brewer JP, Skornik WA, et al (1999) Mast cell activation is not required for induction of airway hyperresponsiveness by ozone in mice. J Appl Physiol 86:202–210
Ozaki A, Fukushima A, Fukata K, et al (2000) Effects of IL-4 and IL-12 on experimental immune-mediated blepharoconjunctivitis in Brown Norway rats. Clin Exp Immunol 122:28–34
Pradalier A (1993) Late-phase reaction in asthma: basic mechanisms. Int Arch Allergy Immunol 101:322–325
Rioux F, Kerouac R, St-Pierre S (1985) Potency of various peptides as histamine liberators in the rat hind limb. Neuropeptides 6:311–319
Romagnani S (2001) T-cell responses in allergy and asthma. Curr Opin Allergy Clin Immunol 1:73–78
Rothenberg ME, MacLean JA, Pearlman E, et al (1997) Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J Exp Med 185:785–790
Sengoku T, Sato S, Sakuma S, et al (2001) Characterization of Ascaris-induced biphasic skin allergic reaction model in mice: possible roles of mast cells in early-phase and CD4-positive T cells in late-phase reactions. Pharmacology 63:82–89
Teixeira MM, Wells TN, Lukacs NW, et al (1997) Chemokine-induced eosinophil recruitment. Evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin. J Clin Invest 100:1657–1666
Teran LM (2000) CCL chemokines and asthma. Immunol Today 21:235–242
Tonnel AB, Gosset P, Molet S, et al (1996) Interactions between endothelial cells and effector cells in allergic inflammation. Ann N Y Acad Sci. 31;796:9–20
Yamada N, Kadowaki S, Umezu K (1992) Development of an animal model of late asthmatic response in guinea pigs and effects of anti-asthmatic drugs. Prostaglandins 43:507–521
Ying S, Meng Q, Zeibecoglou K, et al (1999) Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics. J Immunol 163:6321–6329
Yoshida O, Yoshida H, Iwamoto H, et al (1999) Genetic background determines the nature of immune responses and experimental immune-mediated blepharoconjunctivitis (EC). Curr Eye Res 18:117–124
Acknowledgements
This work was partially supported by a Grant-in-Aid for Encouragement of Young Scientists from the Ministry of Education, Science and Culture, Japan (to A.F.), a Kochi Shinyokinko Anshintomonokai Award and a President Fund of Kochi Medical School Hospital.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ozaki, A., Fukushima, A., Fukata, K. et al. Mast-cell activation augments the late phase reaction in experimental immune-mediated blepharoconjunctivitis. Graefe's Arch Clin Exp Ophthalmol 241, 394–402 (2003). https://doi.org/10.1007/s00417-003-0641-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-003-0641-9